Cargando…
Detection of a GLIS3 fusion in an infant with AML refractory to chemotherapy
Infants diagnosed with acute myeloid leukemia (AML) frequently harbor cytogenetically cryptic fusions involving KMT2A, NUP98, or GLIS2. Those with AML driven specifically by CBFA2T3::GLIS2 fusions have a dismal prognosis and are currently risk-stratified to receive hematopoietic stem cell transplant...
Autores principales: | Smith, Stephen M., Lee, Alex G., Tong, Schuyler, Leung, Stanley G., Hongo, Henry, Rivera, Jose M., Sweet-Cordero, E. Alejandro, Michlitsch, Jennifer, Stieglitz, Elliot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528968/ https://www.ncbi.nlm.nih.gov/pubmed/35927023 http://dx.doi.org/10.1101/mcs.a006220 |
Ejemplares similares
-
GLIS1, a potential candidate gene affect fat deposition in sheep tail
por: Luo, Rongsong, et al.
Publicado: (2021) -
Targeting SLMAP-ALK—a novel gene fusion in lung adenocarcinoma
por: Pagan, Carlos, et al.
Publicado: (2019) -
A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma
por: Hsiao, Susan J., et al.
Publicado: (2017) -
Diffuse midline glioma with novel, potentially targetable, FGFR2–VPS35 fusion
por: Zanazzi, George, et al.
Publicado: (2020) -
A case of KMT2A–SEPT9 fusion–associated acute megakaryoblastic leukemia
por: Forlenza, Christopher J., et al.
Publicado: (2018)